
簡(jiǎn)介:氟伐他汀,Fluvastatin (Leschol)能抑制HMG-CoA還原酶活性,IC50為8 nM。
氟伐他汀物理化學(xué)性質(zhì):
| 
			 密度  | 
			
			 1.2±0.1 g/cm3  | 
		
| 
			 沸點(diǎn)  | 
			
			 681.8±55.0 °C at 760 mmHg  | 
		
| 
			 熔點(diǎn)  | 
			
			 194-197oC  | 
		
| 
			 分子式  | 
			
			 C24H26FNO4  | 
		
| 
			 分子量  | 
			
			 411.466  | 
		
| 
			 閃點(diǎn)  | 
			
			 366.1±31.5 °C  | 
		
| 
			 精確質(zhì)量  | 
			
			 411.184601  | 
		
| 
			 PSA  | 
			
			 82.69  | 
		
| 
			 LogP  | 
			
			 3.62  | 
		
| 
			 外觀性狀  | 
			
			 固體  | 
		
| 
			 蒸汽壓  | 
			
			 0.0±2.2 mmHg at 25°C  | 
		
| 
			 折射率  | 
			
			 1.587  | 
		
氟伐他汀詳細(xì)介紹:
| 
			 中文名稱:  | 
			
			 氟伐他汀  | 
		
| 
			 中文別名:  | 
			
			 氟伐他汀;7-[3-(4-氟苯基)-1-(1-甲基乙基)-1H-吲哚-2-基]-3,5-二羥基-6-庚烯酸;FDH(氟伐他汀中間體);富伐他丁;氟伐地汀;氟伐他汀中間體  | 
		
| 
			 英文名稱:  | 
			
			 Fluvastatin  | 
		
| 
			 英文別名:  | 
			
			 Fluvastatin;7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1h-indol-2-yl)-3,5-dihydroxy-6-heptenoic acid;Methyl-(±)-(E)-7-[3’-(4’-fluoro-phenyl )-1’-(1’-methylethyl)indol-2’-yl]-3,5- dihydroxy-6- heptenoate;(3R,5S,E)-7-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid;6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3R,5S,6E)-rel-;FLUVASTATIN NA;FLUVASTATIN SODIUM;Lescol;Lipaxan;Primexin  | 
		
| 
			 CAS號(hào):  | 
			
			 93957-54-1  | 
		
| 
			 分子式:  | 
			
			 C24H26NO4F  | 
		
| 
			 分子量:  | 
			
			 411.47  | 
		
| 
			 詳細(xì)描述:  | 
			
			 博飛美科提供93957-54-1,氟伐他汀,F(xiàn)luvastatin,Perfemiker,上?,F(xiàn)貨。 Perfemiker,致力于提供高品質(zhì)、高性價(jià)比小分子化合物的產(chǎn)品。 Perfemiker小分子化合物大量庫存,提供超過2萬種的抑制劑、激動(dòng)劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應(yīng)商。 HMGCR抑制劑,Fluvastatin (Leschol)能抑制HMG-CoA還原酶活性,IC50為8 nM。 查詢關(guān)鍵詞:“93957-54-1,氟伐他汀,Fluvastatin,Perfemiker,上海現(xiàn)貨”。  | 
		
氟伐他汀參考文獻(xiàn):
[1]. Araújo FA, Rocha MA, Capettini LS, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (fluvastatin) decreases inflammatory angiogenesis in mice. APMIS. 2012 24. [Epub ahead of print]
[2]. Makabe S, Takahashi Y, Watanabe H, et al. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway. Atherosclerosis. 2010 Dec;213(2):377-84.
[3]. Zhang W, Wu J, Zhou L, et al. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol. 2010 Dec;48(12):1167-74.
[4]. Scripture CD, Pieper JA. Clinical pharmacokinetics of fluvastatin. Clin Pharmacokinet. 2001;40(4):263-81.
                
                
滬公網(wǎng)安備31011402010658號(hào)